VTYX - Wall Street Estimates - Ventyx Biosciences, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.495

-5.38 %

$ 106 M

Market Cap

-0.76

P/E

Price Target Average

635.79%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

53.54%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Ventyx Biosciences, Inc.

Wall Street analysts predict an average 1-year price target for VTYX of $11 , with forecasts ranging from a low of $6 to a high of $16 .

VTYX Lowest Price Target Wall Street Target

6 USD 301.34%

VTYX Average Price Target Wall Street Target

11 USD 635.79%

VTYX Highest Price Target Wall Street Target

16 USD 970.23%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free